We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA/EMA Strategic Plan Targets Drug Treatments for Gaucher in Kids
FDA/EMA Strategic Plan Targets Drug Treatments for Gaucher in Kids
Clinical investigators looking to develop new therapies for children with Gaucher disease may use multi-company, multi-arm trials or data extrapolation techniques, according to a joint strategic plan released by the FDA and European Medicines Agency.